Aveanna Healthcare Holdings Inc (AVAH) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jul 04 2026 to Jun 28 2025 - CSIMarket
CSIMarket
 


Aveanna Healthcare Holdings Inc   (NASDAQ: AVAH)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Aveanna Healthcare Holdings Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Aveanna Healthcare Holdings Inc's ROI in the second quarter of 2026?
Aveanna Healthcare Holdings Inc achieved a return on average invested assets (ROI) of 17.38 % in its second quarter of 2026, this is above AVAH's average return on investment of -8.26%.
Aveanna Healthcare Holdings Inc invested over the 12 months ending in its second quarter of 2026 $1,581 million

ROI decreased relative to the period ending Apr 04 2026, due to the decline in net income.

Within the Healthcare sector 50 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jul 04 2026 quarter, so far to 437, from total ROI ranking in the first quarter of 2026 at 1606.

Definition and Formula of Return on Investment



Return On Investment (Jul 04 2026)
II. Quarter
(Apr 04 2026)
I. Quarter
(Jan 03 2026)
IV. Quarter
(Sep 27 2025)
III. Quarter
(Jun 28 2025)
II. Quarter
Y / Y Investment Change TTM 28.87 % 26.83 % 22.53 % 13.24 % 6.07 %
Y / Y Net Income Change TTM 1380.8 % 4710.41 % 92506.58 % - 33.43 %
Investment (TTM) in Millions 1,705 1,631 1,587 1,400 1,356
Return On Investment (TTM) 17.38 % 17.51 % 16.03 % 5.82 % 1.51 %
AVAH's Overall Ranking # 437 # 1606 # 2344 # 1179 # 1567
Seq. Investment Change TTM 5.85 % 6.41 % 8.34 % 5.62 % 4.17 %
Seq. Net Income Change TTM 5.07 % 16.2 % 198.21 % 306.69 % 241.34 %
Net Income (TTM) in Millions 275 261 225 75 19




Return On Investment AVAH's Ranking
Within: No.
Industry # 1
Sector # 51
Overall # 437

Return On Investment Statistics
High Average Low
16.38 %
-8.26 %
-48.73 %
(Apr 04 2026)   (Apr 01 2023)







Financial Statements
Aveanna Healthcare Holdings Inc's II. Quarter Investments $ 1,705 Millions AVAH's Balance sheet
Aveanna Healthcare Holdings Inc's II. Quarter Income $ 40 Millions Quarterly AVAH's Income Statement
AVAH's Income by Division See AVAH's Income by Division


AVAH Annual Return On Investment (Jan 03 2026)
2026
(Dec 28 2024)
2024
(Dec 30 2023)
2023
(Dec 31 2022)
2022

Total Investments in Millions 1,482 1,155 1,150 1,275 0
Y / Y Investment Growth 28.28 % 0.47 % -9.83 % - -
Net Income in Millions 225 -11 -135 -662 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment 15.19 % -0.95 % -11.7 % -51.92 % -


Annual Roi Comment
In the fiscal year 2026 ROI improved to 15.19 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
AVAH's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for AVAH's Competitors
Subscribers only: Roi for Aveanna Healthcare Holdings Inc's Suppliers
Subscribers only: Return On Investment for AVAH's Customers

Other Ratios
AVAH's Roa AVAH's Inventory Turnover Ratio AVAH's Growth Rates AVAH's Dividend Statistics
AVAH's Profitability Ratios AVAH's Asset Turnover Ratio AVAH's Dividend Growth
AVAH's Roe AVAH's Valuation Ratios AVAH's Financial Strength Ratios AVAH's Dividend Payout Ratio



Companies with similar Return On Investment at Jul 04 2026, within Healthcare Sector ROI
Q32 Bio Inc   47.43 %
Vaxart Inc   46.17 %
Liquidia Corporation  42.09 %
Tg Therapeutics Inc   39.26 %
Medpace Holdings Inc   35.54 %
Mettler toledo International Inc   34.41 %
Eli Lilly And Company  33.95 %
Acadia Pharmaceuticals Inc   31.05 %
Caredx Inc   29.42 %
Adma Biologics Inc   28.94 %
Protalix Biotherapeutics inc   25.72 %
Pro dex Inc   24.29 %
Innoviva Inc   23.33 %
Electromed Inc   23.18 %
Zevra Therapeutics Inc   22.90 %
Iradimed Corporation  22.57 %
Alnylam Pharmaceuticals Inc   22.10 %
Eton Pharmaceuticals Inc   21.31 %
Dexcom Inc   20.98 %
Healthcare Services Group Inc   20.93 %
Arcutis Biotherapeutics Inc   20.77 %
Chemed Corporation  20.13 %
Resmed Inc   20.01 %
Halozyme Therapeutics Inc   19.99 %
Vertex Pharmaceuticals Inc  19.97 %
Agilent Technologies inc   19.84 %
Illumina Inc   19.61 %
Puma Biotechnology Inc   19.60 %
United Therapeutics Corporation  19.53 %
Zoetis Inc   19.44 %


Date modified: 2026-09-26T07:39:23+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.